Literature DB >> 8655208

First case of HIV-1 subtype 0 infection in Germany.

H Hampl1, D Sawitzky, M Stöffler-Meilicke, A Groh, M Schmitt, J Eberle, L Gürtler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8655208     DOI： 10.1007/bf01713567

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  8 in total

1.  Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.

Authors:  L G Gürtler; L Zekeng; F Simon; J Eberle; J M Tsague; L Kaptue; S Brust; S Knapp
Journal:  J Virol Methods       Date:  1995-02       Impact factor: 2.014

2.  Sensitivity of screening kits for anti-HIV-1 subtype O antibodies.

Authors:  F Simon; T D Ly; A Baillou-Beaufils; V Fauveau; J De Saint-Martin; I Loussert-Ajaka; M L Chaix; S Saragosti; A M Courouce; D Ingrand
Journal:  AIDS       Date:  1994-11       Impact factor: 4.177

3.  Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results.

Authors:  L Zekeng; L Gurtler; E Afane Ze; A Sam-Abbenyi; G Mbouni-Essomba; E Mpoudi-Ngolle; M Monny-Lobe; J B Tapka; L Kaptue
Journal:  AIDS       Date:  1994-11       Impact factor: 4.177

4.  Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.

Authors:  C Schable; L Zekeng; C P Pau; D Hu; L Kaptue; L Gurtler; T Dondero; J M Tsague; G Schochetman; H Jaffe
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

5.  Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group.

Authors:  P Charneau; A M Borman; C Quillent; D Guétard; S Chamaret; J Cohen; G Rémy; L Montagnier; F Clavel
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

6.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

Authors:  M Vanden Haesevelde; J L Decourt; R J De Leys; B Vanderborght; G van der Groen; H van Heuverswijn; E Saman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Authors:  L G Gürtler; P H Hauser; J Eberle; A von Brunn; S Knapp; L Zekeng; J M Tsague; L Kaptue
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.

Authors:  I Loussert-Ajaka; T D Ly; M L Chaix; D Ingrand; S Saragosti; A M Couroucé; F Brun-Vézinet; F Simon
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321
  8 in total
  11 in total

1.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Recent aspects of HIV and HIV-related diseases.

Authors:  L Gürtler
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

3.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple.

Authors:  M O Salminen; J K Carr; D L Robertson; P Hegerich; D Gotte; C Koch; E Sanders-Buell; F Gao; P M Sharp; B H Hahn; D S Burke; F E McCutchan
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 5.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

7.  Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.

Authors:  Silvia Geuenich; Lars Kaderali; Ina Allespach; Serkan Sertel; Oliver T Keppler
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

8.  Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.

Authors:  M E Quiñones-Mateu; J L Albright; A Mas; V Soriano; E J Arts
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.

Authors:  A S Vallari; R K Hickman; J R Hackett; C A Brennan; V A Varitek; S G Devare
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

10.  HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integrase.

Authors:  Agnès Depatureaux; Peter K Quashie; Thibault Mesplède; Yingshan Han; Hannah Koubi; Jean-Christophe Plantier; Maureen Oliveira; Daniela Moisi; Bluma Brenner; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.